Hospital Nacional Sergio E. Bernales

Lima Lima 41

0 studies enrolling now · 2 studies all time

What they study most

COVID-19 Pneumonia, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Multidrug Resistant, Tuberculosis, Pulmonary

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia — Completed
• A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) — Completed